hBD-1 vs Clavanin A
Head-to-head comparison of hBD-1 (Human beta-defensin 1) and Clavanin A (Clavanin A (tunicate-derived antimicrobial peptide)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | hBD-1 | Clavanin A |
|---|---|---|
| Category | Dental & Oral | Marine-Derived |
| Full Name | Human beta-defensin 1 | Clavanin A (tunicate-derived antimicrobial peptide) |
| Molecular Weight | 4490 Da | ~2.6 kDa |
| Half-Life | minutes to hours | NR |
| Amino Acids | 36 | 23 |
| Typical Dose | 1-10 µg/mL in experimental studies | NR |
| Route | Topical/Intraoral | in vitro|topical preclinical |
| Purity | ≥98% | ≥98% |
| Studies Count | 85 | 83 |
| Research Status | Pre-clinical | Pre-clinical |
hBD-1 Benefits
- ✓oral innate immunity
- ✓broad antimicrobial activity
- ✓biofilm suppression
- ✓periodontal support
Clavanin A Benefits
- ✓antibacterial
- ✓anti-inflammatory
- ✓wound-healing lead
hBD-1 Dosing
topical peptide exposure|cell-culture or mucosal models|repeat low-dose application in research
Clavanin A Dosing
NR|NR
hBD-1 Side Effects
- ⚠protease degradation
- ⚠local irritation at high dose
- ⚠limited stability in saliva
Clavanin A Side Effects
- ⚠hemolysis at high concentrations
- ⚠immunogenicity risk
- ⚠protease sensitivity
Research Overview
hBD-1
hBD-1 has been studied as part of the oral mucosal defense system and is linked to host resistance against dental pathogens. Research spans periodontitis, candidiasis, and epithelial barrier biology.
Clavanin A
Preclinical work supports broad antibacterial activity and some host-modulating effects, especially in skin and wound models. Activity can be improved through sequence optimization and formulation strategies.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.